News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Genentech, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
BioForest
Genentech Reveals Their Greatest Source of Who They Hire
January 7, 2015
·
2 min read
Business
23andMe, Genentech Forge $60 Million Parkinson’s Research Deal
January 6, 2015
·
2 min read
Business
Phylogica Ltd. Grabs $142 Million Deal With Genentech
December 22, 2014
·
1 min read
Drug Development
FDA Breakthrough Status For Genentech’s Lucentis
December 16, 2014
·
2 min read
Business
Gilead Sciences, Inc. Poaches Genentech Exec To Head Cancer Drug Program
December 15, 2014
·
3 min read
Policy
Genentech Submits NDA For Skin Cancer Med Cobimetinib
December 15, 2014
·
2 min read
Business
Genentech’s R&D Chief To Retire; Small Molecule Head Takes Over Top Spot
December 12, 2014
·
2 min read
Policy
Doctors Who Promote More Expensive Eye Drug Are Among The Highest-Paid Genentech Consultants
December 9, 2014
·
2 min read
Biotech Bay
Genentech Defends Supply Shift For Top Cancer Drugs
November 25, 2014
·
2 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Genentech to Present Extensive Data Showcasing Its Industry-Leading Ophthalmology Portfolio at ARVO 2026
April 30, 2026
·
15 min read
Press Releases
Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026
April 30, 2026
·
11 min read
Press Releases
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc
April 23, 2026
·
20 min read
Press Releases
Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS
April 22, 2026
·
15 min read
Press Releases
Genentech’s Enspryng (Satralizumab) Reduces Risk of Relapses by 68% Demonstrating Potential to Become First Treatment for MOGAD
April 22, 2026
·
12 min read
Press Releases
Roche’s ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD
April 21, 2026
·
9 min read
Press Releases
CORRECTING and REPLACING FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus
April 21, 2026
·
15 min read
Press Releases
FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus
April 21, 2026
·
14 min read
Press Releases
Roche expands mass spectrometry menu to include steroid assays receiving CLIA ‘moderate complexity’ designation
March 18, 2026
·
4 min read
Press Releases
Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer
March 9, 2026
·
7 min read
